Close Menu

NEW YORK (GenomeWeb) – The Wistar Institute and the Helen F. Graham Cancer Center & Research Institute have announced a partnership for gene editing in cancer research.

Under the terms of the partnership, Graham's Gene Editing Institute will be integrated into Wistar's Molecular Screening Facility, though it will keep its management structure and will continue to be located on the Christiana Hospital Campus in Newark, Delaware.

Financial and other terms of the agreement were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Sponsored by

Diverse components of the UC Davis campus have been mobilized to deploy HTP testing to provide a safe working environment and keep the pandemic under control.